Novavax falls short of quarterly expectations, yet the vaccine manufacturer reduces losses by cutting expenses.

Novavax, the vaccine manufacturer, reported Q4 revenue and earnings below Wall Street estimates on Wednesday, emphasizing its ongoing efforts to cut costs and remain financially stable. Despite a decline in demand for its Covid vaccine and other virus-related products worldwide, the company managed to narrow losses compared to the same quarter last year.

Here are Novavax’s Q4 results compared to Wall Street expectations, based on an LSEG analyst survey:

  • Loss per share: $1.44 (actual) vs. expected loss of 45 cents
  • Revenue: $291.3 million (actual) vs. expected $322 million

The company recorded a net loss of $178.4 million, or $1.44 per share, for the quarter, an improvement from the $182.2 million loss, or $2.28 per share, in the same quarter the previous year. Novavax’s Q4 sales were $291.3 million, down from $357.4 million in the corresponding period in the previous year.

Novavax CEO John Jacobs explained that some revenue had shifted from 2023 to 2024 due to the timing of advance purchase agreements for its Covid shot, clarifying it as a timing element rather than lost sales.

Looking ahead, Novavax anticipates full-year 2024 revenue between $800 million and $1 billion. This projection includes expected revenue from dose delivery schedules and commercial market product sales. Analysts surveyed by LSEG, however, expect 2024 revenue to be around $969.6 million.

For Q1 2024, Novavax forecasts revenue of $100 million, reflecting the conclusion of the current Covid vaccination season, a decrease from the previously expected $300 million.

The company reiterated its commitment to cost-cutting and plans to reduce combined research, development, selling, general, and administrative expenses to a range of $700 million to $800 million in 2024. Novavax had already reduced these expenses to $1.21 billion last year, down from $1.69 billion in 2022. Operating expenses in 2023 were cut by $1.1 billion (41%) compared to 2022, and the workforce was reduced by 30% compared to Q1 2023.

These financial results follow concerns raised by Novavax about its financial stability a year ago, with shares falling more than 50% in the previous year. However, the stock received a significant boost last week when the company resolved a dispute with Gavi, a global vaccine organization, regarding a canceled Covid vaccine purchase agreement. Novavax may pay $300 to $400 million, depending on Gavi’s future vaccine orders over the next five years.

MicroStrategy, a Bitcoin-focused company, experiences a 27% surge in its value over a two-day period, propelled by the increase in the company’s cryptocurrency holdings, which now stand at $11 billion.

MicroStrategy’s HODL strategy continues to benefit investors, with the company announcing the acquisition of an additional 3,000 bitcoins, totaling $155 million between February 15 and February 25. As of now, MicroStrategy and its subsidiaries collectively hold approximately 193,000 bitcoins valued at $11 billion.

The company’s chairman and former CEO, Michael Saylor, highlighted the latest bitcoin purchase, emphasizing that MicroStrategy’s average acquisition price stands at $31,544, while the current market price of bitcoin is just under $57,000 as of Tuesday.

Following this announcement, MicroStrategy’s shares witnessed a 16% surge on Monday and an additional 10% increase on Tuesday, closing at $871.80. Despite being primarily involved in enterprise software and cloud-based services, MicroStrategy’s market value is significantly influenced by its substantial bitcoin holdings, effectively making it a key player in the cryptocurrency market.

During the recent earnings call on February 7, CFO Andrew King emphasized MicroStrategy’s commitment to its bitcoin acquisition strategy, asserting its position as the largest corporate holder of bitcoin globally.

Bitcoin has seen a 35% surge in value this year, reaching its highest point since December 2021, while Ether, the second-largest cryptocurrency, has experienced a 42% increase in 2024, reaching around $3,250 on Tuesday.

Investors’ optimism in the bitcoin market has grown, especially after the SEC’s approval of multiple spot bitcoin exchange-traded funds (ETFs) last month. Bitcoin has gained 24% since the introduction of new ETFs on January 11, attracting substantial capital inflows.

The upcoming “halving” event in April, which occurs every four years and reduces the production of bitcoin by half, is also contributing to positive market sentiment. Historically, such halving events have preceded bull runs in the bitcoin price.

MicroStrategy initially announced its plan to invest in bitcoin in mid-2020, committing $250 million over the next 12 months. Since then, the company has experienced a significant increase in bitcoin holdings and witnessed substantial growth in its market cap, reaching almost $15 billion.

Analysts see MicroStrategy’s unique value proposition, as the company has the capability to acquire bitcoin through debt and equity issuances. TD Cowen analysts expect these bitcoin transactions to be accretive to shareholders, highlighting MicroStrategy’s transition from a defensive to an opportunistic strategy for creating shareholder value.

Macy’s plans to shut down approximately 150 department stores, while concurrently inaugurating new outlets for more successful chains.

In pursuit of sales growth, Macy’s announced on Tuesday its decision to close approximately 150 of its namesake stores while simultaneously opening new outlets in strategic locations or those catering to luxury goods. This strategic shift reflects a focus on successful entities within Macy’s portfolio, such as the higher-end Bloomingdale’s department store and the thriving beauty chain Bluemercury. The move comes as Macy’s namesake stores, particularly those in struggling malls, have underperformed in comparison to Bloomingdale’s and Bluemercury, as indicated by the holiday quarter results.

The shift in strategy was shared as part of Macy’s future plans, coinciding with the recent appointment of former Bloomingdale’s CEO Tony Spring as Macy’s CEO on February 4. Macy’s had already announced in January the closure of five namesake stores and the layoff of more than 2,300 employees.

In a CNBC interview, Spring highlighted the company’s initiative to revamp its store footprint by evaluating the profitability and productivity of each location. Macy’s aims to address underproductive and unprofitable stores while also identifying opportunities for expansion in highly productive and profitable markets.

Specifically, Macy’s plans to close about 150 stores, including 50 by early 2025, with a focus on “unproductive” locations. The flagship 400,000-square foot store in San Francisco’s Union Square is among those slated for closure pending a buyer. Macy’s emphasizes its commitment to investing in the approximately 350 namesake stores that will remain open, introducing improvements to customer service and testing smaller store formats in suburban strip malls.

Meanwhile, Bloomingdale’s, outperforming the Macy’s namesake stores, will see growth with the opening of around 15 new stores over the next three years, targeting new markets. The higher-end department store, catering to higher-income and fashion-forward shoppers, has been testing a smaller concept store called Bloomie’s.

Bluemercury, the standout performer among Macy’s brands, is set to expand further, with plans to open at least 30 new stores and remodel approximately 30 existing ones over the next three years. The beauty chain, acquired by Macy’s in 2015 for $210 million, has been testing a new store prototype featuring additional spa services.

In summary, Macy’s strategic adjustments involve closing underperforming namesake stores, expanding successful entities like Bloomingdale’s, and capitalizing on Bluemercury’s positive performance to drive future growth.

Hims & Hers experiences a 31% surge fueled by rapid expansion in mental health, weight loss, and dermatology treatments.

Hims & Hers Health, the online provider offering solutions for erectile dysfunction and hair loss, celebrated its most successful day on the stock market since its debut three years ago. The surge came after quarterly results surpassed expectations, and the company projected its first full year of profitability in 2024.

Closing 31% higher at $13.43 on Tuesday afternoon, Hims & Hers shares have marked a year-to-date increase of over 50%, following a 39% climb in 2023.

Functioning as an online platform facilitating patient interactions with healthcare providers, Hims & Hers provides personalized support for various health aspects, including skincare, mental health, sexual health, weight loss, and hair care. The reported revenue for the period increased by 47% to $246.6 million, surpassing analyst expectations of $246 million, according to LSEG (formerly Refinitiv).

Founded in 2017, the company went public in January 2021 through a special purpose acquisition company. In the fourth quarter, Hims & Hers achieved net income of $1.2 million, or 1 cent per share, a significant improvement from the net loss of $10.9 million, or 5 cents per share, in the previous year.

For the first quarter, the company anticipates revenue growth of at least 40%, ranging between $267 million and $272 million, surpassing analysts’ expectations of $253 million. The full-year revenue is projected to fall between $1.17 billion and $1.2 billion.

During the quarterly investor call, CEO Andrew Dudum highlighted the impact of personalized solutions in attracting new users and sustaining platform engagement. Emerging specialties such as weight loss, mental health, and Hers Dermatology are gaining traction and are expected to contribute over $100 million each in revenue by 2025.

In the realm of mental health, Dudum emphasized the company’s use of artificial intelligence to predict individual patient responses to medication, streamlining the treatment process and avoiding unnecessary trial and error.

Analysts at Jefferies expressed immense satisfaction with the results, comparing them to a fulfilling Thanksgiving dinner. They particularly lauded the stronger-than-expected revenue, profitability, and guidance. Hims & Hers forecasts adjusted earnings of $22 million to $27 million in the first quarter, surpassing the $14 million expected by analysts, according to StreetAccount.

Deutsche Bank analysts, while maintaining a hold rating on the stock, acknowledged Hims & Hers’ strong finish to the year and “meaningfully better-than-expected” 2024 guidance, prompting them to raise their price target from $8 to $14.

Advancements for Black employees in the professional sphere have been noted, yet there remains a significant challenge ahead in their career journey.

Examining the state of Black employment in America reveals a complex narrative. Substantial progress has been achieved during and after the Covid-19 pandemic, but there are still considerable challenges ahead.

Over the nearly four years since the pandemic disrupted the U.S. economy, there has been evident improvement for Black individuals. This includes a notable increase in earnings, surpassing gains for both white and Hispanic counterparts. The unemployment rate for Black workers has dropped more than a percentage point from its January 2020 level, reflecting an overall heightened awareness of workplace inequality.

However, disparities persist, particularly in terms of earnings and representation in certain professions like high-end tech. Some efforts to address these issues have faced criticism, with claims of going too far or being inefficient.

Despite these challenges, there is a prevailing sense of optimism regarding tangible progress. Jessica Fulton, interim president at the Joint Center for Political and Economic Studies, views this recovery as pushing the boundaries of what policymakers previously deemed achievable for Black workers.

Analyzing the data presents encouraging signs. The Black unemployment rate in January stood at 5.3%, slightly up from December but close to the all-time low of 4.8% reached in April 2023. Black employment, totaling nearly 20.9 million people, has risen by 6.3% since February 2020, just before the pandemic hit.

From a financial perspective, there is positive momentum. Black workers’ weekly before-tax earnings have surged by 24.8% since the first quarter of 2020, outpacing increases for white and Hispanic individuals. However, the unemployment rate for white workers remains significantly lower at 3.4% in January.

One notable area of concern is the underrepresentation of Black workers in the technology sector, particularly in management roles. Efforts to address this imbalance have seen varying levels of success, with some companies showcasing exemplary diversity practices, while others lag behind.

The issue of racial bias in technology is pronounced, with 24% of tech workers reporting experiencing racial discrimination at work in 2022, up from 18% the previous year. Initiatives like Rewriting the Code aim to address these challenges by collaborating with workers and companies to promote diversity, particularly focusing on college women.

On a positive note, small businesses like Brooklyn Tea, owned by Ali and Jamila Wright, prioritize hiring from underrepresented groups. The surge in Black-owned businesses, reaching 11% of Black households from 5% in 2019, reflects a positive trend. However, the overall racial dynamics in the U.S. remain precarious, and there is concern about potential setbacks, especially in light of growing hostility towards Diversity, Equity, and Inclusion (DEI) initiatives.

Despite these challenges, the general sentiment is a commitment to finding solutions and continuing the pursuit of equality in the workplace.